Clinical Trial Update: Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating roflumilast in hyperinflated COPD patients using functional respiratory imaging has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

Sponsor: FLUIDDA nv | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 2 | Status: TERMINATED